Toxic epidermal necrolysis caused by fluconazole in a patient with human immunodeficiency virus infection
- PMID: 23129968
- PMCID: PMC3487281
- DOI: 10.4103/0976-500X.99445
Toxic epidermal necrolysis caused by fluconazole in a patient with human immunodeficiency virus infection
Abstract
Stevens-Johnson syndrome and toxic epidermal necrolysis (TEN) are rare but serious dermatologic disorders. These grave conditions present as medical emergency, requiring prompt diagnosis and management. These are often drug induced and various groups of drugs, such as sulfa drugs, NSAIDS, etc., have been implicated as to cause TEN. Fluconazole is a commonly used drug with mild side effects. TEN caused by fluconazole is rare, and till now only few cases have been reported in the literature. We present a case of TEN in a human immunodeficiency virus infected man following fluconazole therapy in view of its rare occurrence.
Keywords: Fluconazole; HIV infection; toxic epidermal necrolysis.
Conflict of interest statement
Figures
Similar articles
-
Fluconazole-induced toxic epidermal necrolysis in a patient with human immunodeficiency virus infection.Dermatology. 1993;187(4):268-9. doi: 10.1159/000247261. Dermatology. 1993. PMID: 8274783
-
Comparison of reporting of Stevens-Johnson syndrome and toxic epidermal necrolysis in association with selective COX-2 inhibitors.Drug Saf. 2005;28(10):917-24. doi: 10.2165/00002018-200528100-00008. Drug Saf. 2005. PMID: 16180941
-
Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis: results of an international prospective study.Arch Dermatol. 2002 Aug;138(8):1019-24. doi: 10.1001/archderm.138.8.1019. Arch Dermatol. 2002. PMID: 12164739
-
Current Perspectives on Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.Clin Rev Allergy Immunol. 2018 Feb;54(1):147-176. doi: 10.1007/s12016-017-8654-z. Clin Rev Allergy Immunol. 2018. PMID: 29188475 Review.
-
Stevens-Johnson syndrome and toxic epidermal necrolysis: A systematic review of PubMed/MEDLINE case reports from 1980 to 2020.Front Med (Lausanne). 2022 Aug 24;9:949520. doi: 10.3389/fmed.2022.949520. eCollection 2022. Front Med (Lausanne). 2022. PMID: 36091694 Free PMC article.
Cited by
-
Toxic epidermal necrolysis in a neonate receiving fluconazole.J Perinatol. 2014 Oct;34(10):792-4. doi: 10.1038/jp.2014.92. J Perinatol. 2014. PMID: 25263725 Review.
-
Management of Stevens-Johnson Syndrome-Toxic Epidermal Necrolysis: Looking Beyond Guidelines!Indian J Dermatol. 2018 Mar-Apr;63(2):117-124. doi: 10.4103/ijd.IJD_583_17. Indian J Dermatol. 2018. PMID: 29692452 Free PMC article.
-
Drug hypersensitivity in HIV infection.Curr Opin Allergy Clin Immunol. 2019 Aug;19(4):272-282. doi: 10.1097/ACI.0000000000000545. Curr Opin Allergy Clin Immunol. 2019. PMID: 31145192 Free PMC article. Review.
-
Skin rash in the intensive care unit: Stevens-Johnson syndrome, toxic epidermal necrolysis, or a rare manifestation of a hidden cutaneous malignancy: A case report.Mol Clin Oncol. 2016 Mar;4(3):413-415. doi: 10.3892/mco.2015.713. Epub 2015 Dec 16. Mol Clin Oncol. 2016. PMID: 26998294 Free PMC article.
References
-
- Backer DS. Toxic epidermal necrolysis. Lancet. 1998;351:1417–20. - PubMed
-
- Bradbury BD, Jick SS. Itraconazole and fluconazole and certain rare, serious adverse events. Pharmacotherapy. 2002;22:697–700. - PubMed
-
- Bennett JE. Antimicrobial Agents – Antifungal agents. In: Brunton LL, Lazo JS, Parker KL, editors. Goodman and Gilman's The Pharmacological Basis of Therapeutics. New York: Mc Graw – Hill; 2006. pp. 1225–41.
-
- Gussenhoven MJ, Haak A, Peereboom-Wynia JD, van’t Wout JW. Stevens-Johnson syndrome after fluconazole. Lancet. 1991;338:120. - PubMed
-
- Azon-Masoliver A, Vilaplana J. Fluconazole-induced toxic epidermal necrolysis in a patient with human immunodeficiency virus infection. Dermatology. 1993;187:268–9. - PubMed
Publication types
LinkOut - more resources
Full Text Sources